L’Oreal reached an agreement to sell 2.3 percent of Sanofi to Sanofi for a total of 3 billion euros.
L’Oreal, according to a statement, L’Oreal, the French pharmaceutical company Sanofi’deki 29.6 million shares, a total of 3 billion euros per share for a total of 3 billion euros to sell Sanofi’ye agreement. After the sale of stocks, as a strong shareholder of L’Oreal Sanofi, he will continue to support the company’s goals to grow and create value.
Following the completion of the purchase agreement, L’Oreal will continue to have 7.2 percent of Sanofi’s capital and 13.1 percent of voting rights.
Stock reproach, which is not subject to any prerequisite, is planned to be completed in the coming days. With this process, L’Oreal is expected to strengthen its balance sheet and further diversify financing resources.
“L’Oreal Finance Director Christophe Babule said in the statement,” We will continue to support Sanofi’s development as a key shareholder in line with the trust -based partnership between L’Oreal and Sanofi. ” He said.
